The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of the COVID-19 pandemic on colorectal cancer (CRC) care: Data from 22 German cancer centers (CC) and the Institute of Pathology, Ruhr-University Bochum - the AIO (Working Group for Internal Oncology of the German Cancer Society) CancerCOVID Consortium - AIO-YMO/KRK 520/ass.
 
Celine Lugnier
Honoraria - Celgene; Taiho Pharmaceutical
 
Sarah Foerster
No Relationships to Disclose
 
Anna-Lena Kraeft
Honoraria - AstraZeneca Japan
 
Inke Sabine Feder
No Relationships to Disclose
 
Jens Christmann
Consulting or Advisory Role - AstraZeneca
 
Eleni Kourti
No Relationships to Disclose
 
Oliver Overheu
No Relationships to Disclose
 
Sabine Sommerlatte
No Relationships to Disclose
 
Waldemar Uhl
No Relationships to Disclose
 
Martin Schoenlein
No Relationships to Disclose
 
Vivian Rosery
No Relationships to Disclose
 
Christoph Biermann
Consulting or Advisory Role - Roche
 
Lothar Müller
No Relationships to Disclose
 
Olaf Schoffer
No Relationships to Disclose
 
Jochen Schmitt
Consulting or Advisory Role - Alkahest; Lilly; Novartis; Sanofi
Research Funding - ALK (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Dominik Paul Modest
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Lilly; Merck Serono; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Sanofi; SERVIER; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Cor2Ed; Incyte; IQvia; Lilly; Merck Serono; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Roche; SERVIER
Research Funding - Amgen (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
Volker Heinemann
Honoraria - Amgen; AstraZeneca; Merck; Pfizer; Pierre Fabre; Roche; Sanofi; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Merck; MSD; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi; Sirtex Medical; TERUMO
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Merck; Roche; SERVIER; Sirtex Medical
 
Jan Schildmann
No Relationships to Disclose
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Roche
 
Andrea Tannapfel
Honoraria - Falk Pharma; Med.Update; Merck; Pfizer